Short answer · Medically reviewed summary · Last updated: 2023-07-13
Cholesteryl Ester Storage Disease (CESD) is a rare genetic disorder that affects the metabolism of cholesterol and fats in the body. It is caused by mutations in the LIPA gene, which provides instructions for producing an enzyme called lysosomal acid lipase (LAL).
Which are the causes of Cholesteryl Ester Storage Disease?
Causes of Cholesteryl Ester Storage Disease explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
Cholesteryl Ester Storage Disease (CESD) is a rare genetic disorder that affects the metabolism of cholesterol and fats in the body. It is caused by mutations in the LIPA gene, which provides instructions for producing an enzyme called lysosomal acid lipase (LAL). LAL plays a crucial role in breaking down cholesteryl esters and triglycerides, which are fatty substances found in various tissues and organs.
When the LIPA gene is mutated, it leads to a deficiency or dysfunction of LAL enzyme activity. As a result, cholesteryl esters and triglycerides accumulate in the lysosomes, which are small compartments within cells responsible for breaking down waste materials. This accumulation primarily affects the liver, spleen, and other organs, leading to the characteristic symptoms of CESD.
The causes of Cholesteryl Ester Storage Disease can be summarized as follows:
- Genetic Mutations: CESD is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated LIPA gene (one from each parent) to develop the disease. If both parents carry a single copy of the mutated gene, each child has a 25% chance of inheriting two copies and developing CESD.
- LAL Enzyme Deficiency: The primary cause of CESD is the deficiency or dysfunction of the LAL enzyme due to genetic mutations. This deficiency impairs the breakdown of cholesteryl esters and triglycerides, leading to their accumulation in lysosomes.
- Accumulation of Cholesteryl Esters and Triglycerides: The accumulation of cholesteryl esters and triglycerides primarily occurs in the liver and spleen. This buildup can cause hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), and other associated symptoms.
- Impaired Lipid Metabolism: The dysfunction of LAL enzyme activity disrupts the normal metabolism of cholesterol and fats in the body. This can result in abnormal lipid profiles, including elevated levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides.
- Variable Disease Severity: The severity of CESD can vary widely among affected individuals. Some individuals may experience mild symptoms during childhood or adulthood, while others may develop more severe forms of the disease that can lead to life-threatening complications.
It is important to note that CESD is a rare disorder, and its exact prevalence is not well-established. However, advancements in genetic testing have improved the diagnosis and understanding of this condition, allowing for better management and treatment options.
